[Endoscopic mucosal resection of Abrikosoff's tumor of the esophagus]

Gastroenterol Hepatol. 2008 Nov;31(9):572-5. doi: 10.1157/13128296.
[Article in Spanish]

Abstract

Abrikosoff's tumor (AT), or granular cell tumor (GCT), is relatively rare in the gastrointestinal tract, where the most common site is the esophagus. This tumor is usually found incidentally when an upper gastrointestinal endoscopy is carried out for another reason. Endoscopically, GCT appears as a small, yellow and submucosal lesion covered by normal mucosa. Endoscopic ultrasonography shows a homogeneous hypoechoic lesion with well defined margins. The definitive diagnosis is histological. The origin of GCT is neurogenic and the tumor is composed of eosinophilic granular cytoplasm and PAS-positive cells, which show the S-100 protein on immunohistochemistry. Although GCT is usually clinically and histologically benign, some malignant cases have been reported. Consensus is lacking on the treatment and follow-up of this tumor. Currently, endoscopic mucosal resection is a safe and effective technique to treat submucosal esophageal lesions, allowing subsequent histologic analysis. We present three patients with esophageal CGT, who were definitively treated with endoscopic mucosal resection.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adult
  • Biomarkers, Tumor / analysis
  • Esophageal Neoplasms / chemistry
  • Esophageal Neoplasms / pathology
  • Esophageal Neoplasms / surgery*
  • Esophagoscopy*
  • Female
  • Granular Cell Tumor / chemistry
  • Granular Cell Tumor / pathology
  • Granular Cell Tumor / surgery*
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Proteins / analysis
  • S100 Proteins / analysis

Substances

  • Biomarkers, Tumor
  • Neoplasm Proteins
  • S100 Proteins